About: Carboplatin-Taxol-Bevacizumab Regimen

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Carboplatin-Taxol-Bevacizumab Regimen Goto Sponge Distinct Permalink

An Entity of Type : owl:Class, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	Class
rdfs:label	Carboplatin-Taxol-Bevacizumab Regimen
rdfs:subClassOf	Chemotherapy Regimen Used to Treat Non-Small Cell Lung Carcinoma nodeID://b656702 nodeID://b656703 nodeID://b656704 nodeID://b656705
Semantic_Type	Therapeutic or Preventive Procedure
Preferred_Name	Carboplatin-Taxol-Bevacizumab Regimen
UMLS_CUI	C1880001
ALT_DEFINITION	A chemotherapy combination used to treat advanced, nonsquamous non-small cell lung cancer. It includes the drugs carboplatin, paclitaxel (Taxol), and bevacizumab.NCI-GLOSS
PDQ_Open_Trial_Search_ID	657275
PDQ_Closed_Trial_Search_ID	657275
Legacy_Concept_Name	Carboplatin-Taxol-Bevacizumab_Regimen
FULL_SYN	carboplatin-Taxol-bevacizumab regimenPTNCI-GLOSSCDR0000663014 Carboplatin-Taxol-Bevacizumab RegimenPTNCI Carbo-Taxol-Avastin RegimenSYNCI carboplatin-paclitaxel-bevacizumab regimenPTNCI-GLOSSCDR0000663013
DEFINITION	A chemoimmunotherapy regimen consisting of carboplatin, paclitaxel and bevacizumab used to treat advanced stage, non-small cell lung cancer which is not of the squamous cell histology.NCI
DesignNote	Source: NCCN Guidelines 2007
code	C63413

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 48 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software